Lantern Pharma (LTRN) Tops Q3 EPS by 14c

Lantern Pharma (NASDAQ: LTRN) reported Q3 EPS of ($0.42), $0.14 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• Kotak Upgrades JSW Steel Ltd (JSTL:IN) to Buy (1)
• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• CLSA Downgrades RBL Bank Ltd. (RBK:IN) to Underperform (4)